Global /Germany /Healthcare /Diagnostics & Research /NN6
chevron_leftBack

NanoRepro AG

NN6
XETRA: NN6 Delayed
1.35EUR -0.4%
1.54 USD
As of 24 April 2025, NanoRepro AG has a market cap of $19.38M USD, ranking #30026 globally and #354 in Germany. It ranks #3007 in the Healthcare sector, and #154 in the Diagnostics & Research industry.
Global Rank
30026
Country Rank
354
Sector Rank
3007
Industry Rank
154
Key Stats
Market Cap
$19.38MUSD
17.03M EUR
Enterprise Value
-$9.98MUSD
-8.77M EUR
Revenue (TTM)
$4.05MUSD
3.56M EUR
EBITDA (TTM)
-$5.45MUSD
-4.79M EUR
Net Income (TTM)
-$3.64MUSD
-3.2M EUR
EBITDA Margin
-134%
Profit Margin
-90%
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Diagnostics & Research
CEO
Lisa Jungst open_in_new
Employees
18
Founded
2006
Website
nanorepro.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-0.4% -1.8% -0.4% -2.5% -22% -22%
Upcoming Earnings
Earnings Date
Thu, Jun 5

Markets

Exchange Ticker Price
Deutsche Börse Xetra
MIC: XETR
PRIMARY
NN6
ISIN: DE0006577109
Shares Out.:
12.904M1 Shares Float: 12.017M2
TV:
SA:
YF:
GF:
BA:
NN6
MS:
1.35 EUR
Frankfurt Stock Exchange
MIC: XFRA
NN6
NanoRepro AG
ISIN: DE0006577109
TV:
SA:
YF:
GF:
BA:
NN6
MS:
1.31 EUR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About NanoRepro AG

NanoRepro AG develops, manufactures, and distributes rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. It provides products in the areas of family planning and disease detection, as well as food intolerances, allergies, and infectious diseases. The company offers rapid diagnostic tests, such as family planning, and preventive healthcare line products; tests for hospitals and medical practices to detect aids, Troponin I, D-dimer, streptococci antigen, influenza type A and B antigens, and microalbumin; and immunochromatographic lateral flow tests for the diagnostic detection of biomarkers, as well as SARS-CoV-2 antibody test and corona antigen rapid test. It also provides food supplements for men and women, including Alphabiol Beauty Elixier for the skin shine based on combination of micronutrients; Alphabiol Fertility for men; Alphabiol Curcumin Elixier mit Curcumin + Vitamin D, an essential nutrient for Vitamin D through online shops and pharmacies. The company was founded in 2006 and is headquartered in Marburg, Germany.

Similar Companies

Industry: Diagnostics & Research (Germany)
Name
Market Cap diff.
Mainz Biomed N.V.
MYNZ
$9.57M
-51%
Centogene N.V.
CNTGF
$4.36M
-77%
Industry: Diagnostics & Research (Global)
Name
Market Cap diff.
Thermo Fisher Scientific Inc.
TMO
$162.94B
841K%
Danaher Corp.
DHR
$140.49B
725K%
Lonza Group AG
LONN
$48.07B
39.7B CHF
248K%
IDEXX Laboratories, Inc.
IDXX
$34.57B
178K%
Agilent Technologies, Inc.
A
$29.94B
154K%